Literature DB >> 24131680

Periprosthetic osteolysis after total ankle arthroplasty.

Hang Seob Yoon1, Jongseok Lee, Woo Jin Choi, Jin Woo Lee.   

Abstract

BACKGROUND: Periprosthetic osteolysis in total ankle arthroplasty (TAA) is a substantial problem. We report the incidence and characteristics of periprosthetic osteolysis and its association with clinical outcomes after TAA using the HINTEGRA ankle system.
METHODS: Between May 2004 and April 2010, 126 primary TAA were performed on 115 patients. We excluded 27 ankles with a follow-up of less than 24 months; thus, 99 ankles in 90 patients with a mean follow-up of 40.8 (range, 24-89) months were included in the study. Pain and clinical outcomes were assessed using the visual analog scale and the American Orthopaedic Foot and Ankle Society score. Fluoroscopy was used for optimum visualization of the bone-implant interfaces on radiographs. Computed tomography (CT) was conducted on 25 ankles that exhibited progression of osteolysis.
RESULTS: Radiographs revealed that 37 of the 99 ankles showed radiologic evidence of osteolysis; of these, 10 demonstrated continuous progression over the study period. Helical CT scans were more accurate than radiographs for identifying and measuring periprosthetic osteolysis in TAA. None of the demographic parameters were substantially different between the 2 groups of subjects (with or without osteolysis). No major association was found between the presence of osteolysis and clinical and radiologic outcomes.
CONCLUSION: Osteolysis associated with TAA may indeed be common in the postoperative period. Although most of the osteolytic lesions observed here were relatively quiescent, these lesions raise concerns in contemporary TAA because of their incidence rate and the potential for later mechanical failure as compared to arthrodesis. Early diagnosis and careful evaluation of osteolysis may provide a clinical opportunity for limited revision surgery in ankles of impending prosthesis failure. LEVEL OF EVIDENCE: Level IV, case series.

Entities:  

Keywords:  HINTEGRA ankle; arthritis; osteolysis; revision; total ankle arthroplasty

Mesh:

Year:  2013        PMID: 24131680     DOI: 10.1177/1071100713509247

Source DB:  PubMed          Journal:  Foot Ankle Int        ISSN: 1071-1007            Impact factor:   2.827


  7 in total

Review 1.  Total ankle replacement.

Authors:  Alexej Barg; Matthias D Wimmer; Martin Wiewiorski; Dieter C Wirtz; Geert I Pagenstert; Victor Valderrabano
Journal:  Dtsch Arztebl Int       Date:  2015-03-13       Impact factor: 5.594

2.  NF-κB/let-7f-5p/IL-10 pathway involves in wear particle-induced osteolysis by inducing M1 macrophage polarization.

Authors:  Xu-Ren Gao; Jian Ge; Wei-Yi Li; Wang-Chen Zhou; Lei Xu; De-Qin Geng
Journal:  Cell Cycle       Date:  2018-09-19       Impact factor: 4.534

3.  Long-term follow-up of Bologna-Oxford (BOX) total ankle arthroplasty.

Authors:  Alberto Bianchi; Nicolò Martinelli; Eleonora Caboni; Giorgio Raggi; Francesca Manfroni; Valerio Sansone
Journal:  Int Orthop       Date:  2021-04-06       Impact factor: 3.075

4.  Total ankle replacement for posttraumatic arthritis. Similar outcome in postfracture and instability arthritis: a comparison of 90 ankles.

Authors:  Rebecca A Nieuwe Weme; Guido van Solinge; Job N Doornberg; Inger Sierevelt; Daniël Haverkamp; H Cornelis Doets
Journal:  Acta Orthop       Date:  2015-03-14       Impact factor: 3.717

5.  Total ankle replacement.

Authors:  Jan Willem K Louwerens
Journal:  Acta Orthop       Date:  2015-05-30       Impact factor: 3.717

6.  LIM Homeobox Transcription Factor 1-β Expression is Upregulated in Patients with Osteolysis after Total Ankle Arthroplasty and Inhibits Receptor Activator of Nuclear Factor-κB Ligand-Induced Osteoclast Differentiation in Vitro.

Authors:  Kabsun Kim; Jeong Eun Han; Keun-Bae Lee; Nacksung Kim
Journal:  J Bone Metab       Date:  2022-08-31

7.  Ballooning osteolysis in 71 failed total ankle arthroplasties.

Authors:  Gurpal Singh; Theresa Reichard; Rita Hameister; Friedemann Awiszus; Katja Schenk; Bernd Feuerstein; Albert Roessner; Christoph Lohmann
Journal:  Acta Orthop       Date:  2016-05-19       Impact factor: 3.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.